Zvi Grunwald, MD, Professor, Chairman, Department of Anesthesiology, James D. Wentzler, Thomas Jefferson University
Dr. Grunwald is the James D. Wentzler Professor and Chairman, Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University. Born in Israel, he received his MD from the Hebrew University Medical School in Jerusalem (1982). He completed a residency in Pediatrics at the Beilinson Medical Center in Petah Tikva, Israel in 1986, and a residency in Anesthesiology at the Hospital of the University of Pennsylvania in 1989. He then completed fellowship training in pediatric anesthesiology and critical care at the Children Hospital of Philadelphia in 1989.
Following his training, Dr. Grunwald joined the faculty of the University of Pennsylvania as Assistant Professor of Anesthesiology, and served as the director of anesthesia for liver and kidney transplantation at the Children’s Hospital of Philadelphia from 1992-1994. He returned to Israel to Chair the Department of Anesthesiology at the Rabin Medical Center in Petah Tikva, Israel 1995-96. Dr. Grunwald has participated in and led the anesthesia teams for the first successful liver transplants at the Hospital of the University of Pennsylvania, the Children’s Hospital of Philadelphia and the Hadassah Medical Center. Currently, Dr. Grunwald oversees the Jefferson Artificial Pancreas Center, a first of its kind. Dr. Grunwald collaborated with Dr. Jeffrey Joseph in his department in the inception of Animas Corporation in 1996 to develop an implantable optical blood glucose sensor. The company had a successful IPO in 2004, and acquired by Johnson & Johnson in 2006. In 2014 Dr. Grunwald sponsored Dr. Jaffrey Joseph in launching two start-up companies: Capillary Biomedical, for the development of a long-term implantable optical monitoring glucose system and insulin delivery system, and RTM Vital Signs, for the development of implantable vital sign sensors and diagnostic/therapeutic algorithm with data to a central monitoring station.
Dr. Grunwald is leading a clinical center of excellence for perioperative management of patients with Fibrodysplasia Ossificans Progressiva (FOP), and serve as consultant for FOP patients from around the world.